Related Experiment Video
Updated: Nov 16, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro
Hua-Long Xiong1, Jia-Li Cao1,2, Chen-Guang Shen3,4
1State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences and School of Public Health, Xiamen University, Xiamen, China.
Abstract:
To identify drugs that are potentially used for the treatment of COVID-19, the potency of 1403 FDA-approved drugs were evaluated using a robust pseudovirus assay and the candidates were further confirmed by authentic SARS-CoV-2 assay. Four compounds, Clomiphene (citrate), Vortioxetine, Vortioxetine (hydrobromide) and Asenapine (hydrochloride), showed potent inhibitory effects in both pseudovirus and authentic virus assay. The combination of Clomiphene (citrate), Vortioxetine and Asenapine (hydrochloride) is much more potent than used alone, with IC50 of 0.34 μM.
Related Concept Videos
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
FDA Approved Drugs: Changes to Approved Drugs
Combined Effects of Drugs: Synergism
Such synergistic combinations...

